- Home
- NMRA vs TSAT Comparison
NMRA vs TSAT Comparison
Compare NMRA & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- TSAT
- Stock Information
- Founded
- NMRA 2019
- TSAT 1969
- Country
- NMRA United States
- TSAT Canada
- Employees
- NMRA N/A
- TSAT N/A
- Industry
- NMRA
- TSAT Metal Fabrications
- Sector
- NMRA
- TSAT Industrials
- Exchange
- NMRA Nasdaq
- TSAT Nasdaq
- Market Cap
- NMRA 268.5M
- TSAT 394.3M
- IPO Year
- NMRA 2023
- TSAT 1996
- Fundamental
- Price
- NMRA $1.45
- TSAT $26.58
- Analyst Decision
- NMRA Hold
- TSAT
- Analyst Count
- NMRA 8
- TSAT 0
- Target Price
- NMRA $5.83
- TSAT N/A
- AVG Volume (30 Days)
- NMRA 376.8K
- TSAT 89.8K
- Earning Date
- NMRA 11-11-2025
- TSAT 11-13-2025
- Dividend Yield
- NMRA N/A
- TSAT N/A
- EPS Growth
- NMRA N/A
- TSAT N/A
- EPS
- NMRA N/A
- TSAT N/A
- Revenue
- NMRA N/A
- TSAT $358,754,564.00
- Revenue This Year
- NMRA N/A
- TSAT N/A
- Revenue Next Year
- NMRA N/A
- TSAT N/A
- P/E Ratio
- NMRA N/A
- TSAT N/A
- Revenue Growth
- NMRA N/A
- TSAT N/A
- 52 Week Low
- NMRA $0.61
- TSAT $10.11
- 52 Week High
- NMRA $17.19
- TSAT $29.91
- Technical
- Relative Strength Index (RSI)
- NMRA 36.91
- TSAT 62.74
- Support Level
- NMRA $1.48
- TSAT $20.81
- Resistance Level
- NMRA $1.70
- TSAT $27.83
- Average True Range (ATR)
- NMRA 0.10
- TSAT 1.43
- MACD
- NMRA -0.03
- TSAT 0.70
- Stochastic Oscillator
- NMRA 7.21
- TSAT 74.00
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.